| 臺大學術典藏 |
2018-09-10T14:51:58Z |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials
|
Tebas, P. and Sension, M. and Arribas, J. and Duiculescu, D. and Florence, E. and Hung, C.-C. and Wilkin, T. and Vanveggel, S. and Stevens, M. and Deckx, H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T03:22:38Z |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials
|
Tebas P.; Sension M.; Arribas J.; Duiculescu D.; Florence E.; CHIEN-CHING HUNG; Wilkin T.; Vanveggel S.; Stevens M.; Deckx H. |
| 臺大學術典藏 |
2022-09-09T05:50:01Z |
Lipid lowering in primary prevention: The lower is better, but where to settle?
|
WEI-SHIUNG YANG |
| 國立成功大學 |
2018-09 |
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients
|
Li;Yi-Heng;Chao;Ting-Hsing;Liu;-Yen, Ping;Ueng;Kwo-Chang;Yeh;Hung-I |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2018-09-10T18:02:50Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? �V Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T. and Yin, W.-H. and Tseng, W.-K. and Lin, F.-J. and Yeh, H.-I. and Chen, J.-W. and Wu, Y.-W. and Wu, C.-C.; FANG-JU LIN; YEN-WEN WU |
| 嘉南藥理大學 |
2021 |
Lipid Metabolism and its Mechanism Triggered by Supercritical CO2 Extract of Adlay (Coix lacryma-jobi var. ma-yuen (Rom. Caill.) Stapf) Bran in High-Fat Diet Induced Hyperlipidemic Hamsters
|
Huang, Chiao-Chih; Lin, Tzu-Ching; Liu, Chiung-Hui; Hu, Hao-Chun; Yu, Szu-Yin; Wu, Shu-Jing; Yen, Ming-Hong; Tsai, Yi-Hong; Chang, Fang-Rong |
